These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 20032549)

  • 1. Initial evaluation of the Roche COBAS TaqMan HIV-1 v2.0 assay for determining viral load in HIV-infected individuals.
    Taylor N; Schmid I; Egle A; Greil R; Patsch W; Oberkofler H
    Antivir Ther; 2009; 14(8):1189-93. PubMed ID: 20032549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between the automated Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 assay and its version 1 and Nuclisens HIV-1 EasyQ version 2.0 assays when measuring diverse HIV-1 genotypes in China.
    Xu S; Song A; Nie J; Li X; Meng S; Zhang C; Wang Y
    J Clin Virol; 2012 Jan; 53(1):33-7. PubMed ID: 22051503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High correlation between the Roche COBAS® AmpliPrep/COBAS® TaqMan® HIV-1, v2.0 and the Abbott m2000 RealTime HIV-1 assays for quantification of viral load in HIV-1 B and non-B subtypes.
    Karasi JC; Dziezuk F; Quennery L; Förster S; Reischl U; Colucci G; Schoener D; Seguin-Devaux C; Schmit JC
    J Clin Virol; 2011 Nov; 52(3):181-6. PubMed ID: 21813320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishing diagnostic cut-off criteria for the COBAS AmpliPrep/COBAS TaqMan HIV-1 Qualitative test through validation against the Amplicor DNA test v1.5 for infant diagnosis using dried blood spots.
    Maritz J; Preiser W; van Zyl GU
    J Clin Virol; 2012 Feb; 53(2):106-9. PubMed ID: 22196872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the clinical sensitivity for the quantification of human immunodeficiency virus type 1 RNA in plasma: Comparison of the new COBAS TaqMan HIV-1 with three current HIV-RNA assays--LCx HIV RNA quantitative, VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 Monitor v1.5.
    Katsoulidou A; Petrodaskalaki M; Sypsa V; Papachristou E; Anastassopoulou CG; Gargalianos P; Karafoulidou A; Lazanas M; Kordossis T; Andoniadou A; Hatzakis A
    J Virol Methods; 2006 Feb; 131(2):168-74. PubMed ID: 16194575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 (CAP/CTM v2.0) with other real-time PCR assays in HIV-1 monitoring and follow-up of low-level viral loads.
    Wojewoda CM; Spahlinger T; Harmon ML; Schnellinger B; Li Q; Dejelo C; Schmotzer C; Zhou L
    J Virol Methods; 2013 Jan; 187(1):1-5. PubMed ID: 23098667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of the Cobas Amplicor HIV-1 Monitor Ultrasensitive Test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples.
    Berger A; Scherzed L; Stürmer M; Preiser W; Doerr HW; Rabenau HF
    J Clin Virol; 2005 May; 33(1):43-51. PubMed ID: 15797364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance evaluation of the COBAS/TaqMan HIV-1 v2.0 in HIV-1 positive patients with low viral load: a comparative study.
    Paba P; Fabeni L; Ciccozzi M; Perno CF; Ciotti M
    J Virol Methods; 2011 May; 173(2):399-402. PubMed ID: 21419171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 3 nucleic acid isolation methods for the quantification of HIV-1 RNA by Cobas Taqman real-time polymerase chain reaction system.
    Alp A; Hascelik G
    Diagn Microbiol Infect Dis; 2009 Apr; 63(4):365-71. PubMed ID: 19232859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of HIV-1 RNA levels in plasma and CSF of asymptomatic HIV-1 infected patients from South India using a TaqMan real time PCR assay.
    Kamat A; Ravi V; Desai A; Satishchandra P; Satish KS; Borodowsky I; Subbakrishna DK; Kumar M
    J Clin Virol; 2007 May; 39(1):9-15. PubMed ID: 17368087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the COBAS AmpliPrep-total nucleic acid isolation-COBAS TaqMan hepatitis B virus (HBV) quantitative test and comparison to the VERSANT HBV DNA 3.0 assay.
    Ronsin C; Pillet A; Bali C; Denoyel GA
    J Clin Microbiol; 2006 Apr; 44(4):1390-9. PubMed ID: 16597867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the NucliSens EasyQ HIV-1 v1.1 and RealTime HIV-1 kits for quantitation of HIV-1 RNA in plasma.
    Choi JY; Kim EJ; Rho HJ; Kim JY; Kwon OK; Lee JH; Koo MJ; Kim SS
    J Virol Methods; 2009 Oct; 161(1):7-11. PubMed ID: 19576640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the rate and size of HIV-1 viral load blips with Roche COBAS TaqMan HIV-1 versions 1.0 and 2.0 and implications for patient management.
    Garrett NJ; Apea V; Nori A; Ushiro-Lumb I; Oliver AR; Baily G; Clark DA
    J Clin Virol; 2012 Apr; 53(4):354-5. PubMed ID: 22261125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive comparison of the VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 MONITOR 1.5 assays on 1,000 clinical specimens.
    Galli R; Merrick L; Friesenhahn M; Ziermann R
    J Clin Virol; 2005 Dec; 34(4):245-52. PubMed ID: 16286047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of elevated HIV-1 viral load results obtained from samples stored frozen in vacutainer plasma preparation tubes.
    Cloherty G; Swanson P; Lucic D; Dieckhaus K; Anthony P; Cataline P; Herman C; Hackett J; Skolnik PR; Chirch L
    J Virol Methods; 2014 Aug; 204():91-2. PubMed ID: 24747107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative RNA quantification of HIV-1 group M and non-M with the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 v2.0 and Abbott Real-Time HIV-1 PCR assays.
    Sire JM; Vray M; Merzouk M; Plantier JC; Pavie J; Maylin S; Timsit J; Lascoux-Combe C; Molina JM; Simon F; Delaugerre C
    J Acquir Immune Defic Syndr; 2011 Mar; 56(3):239-43. PubMed ID: 21164353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Undetectable HIV-1 RNA load with the Cobas TaqMan v1.0 in a patient diagnosed at the time of primary HIV-1 infection.
    Ghosn J; Galimand J; Meyer L; Descamps D; Vabret A; Deveau C; Yéni P; Goujard C; Rouzioux C; Chaix ML;
    J Med Virol; 2010 Nov; 82(11):1816-8. PubMed ID: 20872706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing HIV viral load assays and frequency of low level virological rebound in clinical practice.
    Briggs R; Templeton K; Fernando I
    Int J STD AIDS; 2014 Dec; 25(14):1029-34. PubMed ID: 24648315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA.
    Pas S; Rossen JW; Schoener D; Thamke D; Pettersson A; Babiel R; Schutten M
    J Clin Microbiol; 2010 Apr; 48(4):1195-200. PubMed ID: 20164281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved HIV-1 RNA quantitation by COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, v2.0 using a novel dual-target approach.
    Sizmann D; Glaubitz J; Simon CO; Goedel S; Buergisser P; Drogan D; Hesse M; Kröh M; Simmler P; Dewald M; Gilsdorf M; Fuerst M; Ineichen R; Kirn A; Pasche P; Wang Z; Weisshaar S; Young K; Haberhausen G; Babiel R
    J Clin Virol; 2010 Sep; 49(1):41-6. PubMed ID: 20637687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.